全文获取类型
收费全文 | 138152篇 |
免费 | 10328篇 |
国内免费 | 5686篇 |
专业分类
耳鼻咽喉 | 493篇 |
儿科学 | 2239篇 |
妇产科学 | 2293篇 |
基础医学 | 23923篇 |
口腔科学 | 1566篇 |
临床医学 | 9131篇 |
内科学 | 26885篇 |
皮肤病学 | 2103篇 |
神经病学 | 12755篇 |
特种医学 | 2107篇 |
外国民族医学 | 28篇 |
外科学 | 7936篇 |
综合类 | 17882篇 |
现状与发展 | 26篇 |
预防医学 | 7632篇 |
眼科学 | 1064篇 |
药学 | 21219篇 |
26篇 | |
中国医学 | 4890篇 |
肿瘤学 | 9968篇 |
出版年
2024年 | 245篇 |
2023年 | 1568篇 |
2022年 | 3218篇 |
2021年 | 4189篇 |
2020年 | 3809篇 |
2019年 | 4031篇 |
2018年 | 4028篇 |
2017年 | 4037篇 |
2016年 | 4469篇 |
2015年 | 5044篇 |
2014年 | 8213篇 |
2013年 | 9675篇 |
2012年 | 8291篇 |
2011年 | 9202篇 |
2010年 | 7554篇 |
2009年 | 7476篇 |
2008年 | 7747篇 |
2007年 | 7271篇 |
2006年 | 6488篇 |
2005年 | 5586篇 |
2004年 | 4918篇 |
2003年 | 4408篇 |
2002年 | 3582篇 |
2001年 | 3106篇 |
2000年 | 2646篇 |
1999年 | 2311篇 |
1998年 | 2401篇 |
1997年 | 2159篇 |
1996年 | 1913篇 |
1995年 | 1668篇 |
1994年 | 1479篇 |
1993年 | 1295篇 |
1992年 | 1069篇 |
1991年 | 947篇 |
1990年 | 753篇 |
1989年 | 658篇 |
1988年 | 557篇 |
1987年 | 491篇 |
1986年 | 471篇 |
1985年 | 800篇 |
1984年 | 759篇 |
1983年 | 547篇 |
1982年 | 628篇 |
1981年 | 515篇 |
1980年 | 433篇 |
1979年 | 346篇 |
1978年 | 268篇 |
1977年 | 210篇 |
1976年 | 215篇 |
1975年 | 189篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Kathleen Hawker 《Annals of Indian Academy of Neurology》2009,12(4):221-225
B cells have recently been identified as an integral component of the immune system; they play a part in autoimmunity through antigen presentation, antibody secretion, and complement activation. Animal models of multiple sclerosis (MS) suggest that myelin destruction is partly mediated through B cell activation (and plasmablasts). MS patients with evidence of B cell involvement, as compared to those without, tend to have a worse prognosis. Finally, the significant decrease in new gadolinium-enhancing lesions, new T2 lesions, and relapses in MS patients treated with rituximab (a monoclonal antibody against CD20 on B cells) leads us to the conclusion that B cells play an important role in MS and that immune modulation of these cells may ameliorate the disease. This article will explore the role of B cells in MS and the rationale for the development of B cell–targeted therapeutics. MS is an immune-mediated disease that affects over 2 million people worldwide and is the number one cause of disability in young patients. Most therapeutic targets have focused on T cells; however, recently, the focus has shifted to the role of B cells in the pathogenesis of MS and the potential of B cells as a therapeutic target. 相似文献
32.
33.
34.
35.
E. Wieczerzak E. Jankowska S. Rodziewicz‐Motowido A. Giedo J. giewka Z. Grzonka M. Abrahamson A. Grubb D. Brmme 《Chemical biology & drug design》2005,66(Z1):1-11
Abstract: We have designed and synthesized a new series of azapeptides which act as potential inhibitors of cathepsin B and/or cathepsin K. Their structures are based upon the inhibitory sites of natural cysteine protease inhibitors, cystatins. For the synthesized azapeptides, the equilibrium constants for dissociation of inhibitor–enzyme complex, Ki, were determined. Comparison of these values indicated that all of the azainhibitors act much stronger toward cathepsin B. Z‐Arg‐Leu‐His‐Agly‐Ile‐Val‐OMe ( 7 ) proved to be approximately 500 times more potent for cathepsin B than for cathepsin K. To be able to explain the obtained experimental values we used the molecular dynamics procedures to analyze the interactions between cathepsin B and compound 7 . We also determined the structure of the most potent and selective cathepsin B azainhibitor by means of NMR studies and theoretical calculations. In this report, we describe SAR studies of azapeptide inhibitors indicating the influence of the conformational flexibility of the examined compounds on inhibition of cathepsins B and K. 相似文献
36.
子宫腺肌症病变中雌激素、孕激素、癌基因、凋亡抑制基因的表达研究 总被引:1,自引:1,他引:0
目的 研究雌激素(ER)、孕激素(PR)及癌基因(cerbB-2)、凋亡抑制基因(Bcl-2)在子宫腺肌症病变中的表达和子宫腺肌症发病的相关性。方法 用免疫组化方法检测40例子宫腺肌症病变组织中ER及其他生物学指标的表达。结果 ER、PR与CerbB.2、Bcl-2在子宫腺肌症病变中均有不同程度的阳性表达,子宫肌层异位内膜ER阳性表达率97.5%,PR阳性率97.5%,cerbB-2阳性率82.5%,Bcl-2阳性率62.5%。在位内膜和异位内膜ER、PR均呈阳性,阳性率比较差异无统计学意义(P〉0.05)。异位内膜cerbB-2的强阳性率高于在位内膜,差异有统计学意义(P〈0.05)。ER、PR与cerbB-2、Bcl-2阳性率相比具有相关性(P〈0.05)。结论 ER、PR与cerbB.2、Bcl-2在异位内膜高表达,提示这些生物学指标在子宫腺肌症发生发展中发挥作用。 相似文献
37.
38.
T Kato M Itoh J Hanashita T Itoi T Matsumoto Y Ono S Imamura N Hayakawa A Suzuki Y Mizutani Y Uchigata N Oda 《Diabetic medicine》2007,24(11):1279-1281
AIMS: A rare case of the insulin autoimmune syndrome (IAS) accompanied by insulin receptor anomaly is reported. METHODS: Antibodies to insulin and insulin receptor were determined in the patient with severe hypoglycaemia before and after the treatment with prednisolone. RESULTS: Titers of antibody to insulin and insulin receptors were 73.0% and 41.5%, respectively. Drug-induced lymphocyte stimulation tests were all negative for the suspicious drugs. Her HLA-DR was DRB1*0403/04051. Following steroid therapy, the formation of antibodies was suppressed and alleviated her symptoms. Scatchard analysis yielded findings specific to polyclonal antibodies. CONCLUSIONS: The changes in autoantibodies resulted in alleviation of the hypoglycemic symptoms as a result of steroid therapy. 相似文献
39.
40.
目的探讨复方丹参注射液联合干扰素治疗慢性乙肝患者的疗效。方法110例慢性乙肝患者,按随机方法分成①对照组30例,应用普通保肝药物治疗,疗程6个月;②丹参组30例,应用复方丹参注射液(每ml含丹参、降香各1g)30ml加入10%葡萄糖溶液300ml中静脉注射1个月;③IFN组30例,应用IFN—α 3MU,隔日一次肌内注射,3个月;④联合组20例,应用复方丹参注射液30ml加10%葡萄糖溶液300ml静脉注射1个月,IFN-α 3MU,隔日一次肌内注射,3个月。丹参组,IFN组和联合组保肝药物治疗同对照组。四组病例在性别、年龄、病程,治疗前肝功能等方面均无统计学差异。治疗前检测肝功能,肝炎病毒标志,血清HA、IV—C、PCI—Ⅱ,部分病例进行肝穿病理检查。治疗开始后每月检测肝功能,3个月(治疗后)和6个月(随访时)时检测血清HA、IV—C、PCⅢ及乙肝病毒标志,治疗后1年行肝穿病理检查。结果治疗前四组患者血清HA、PCⅢ、IV—C水平无统计学差异;治疗后丹参组、IFN组、联合组血清HA、FCⅢ、IV—C水平较治疗前及对照组有不同程度的降低。结论复方丹参注射液联合IFN治疗可使血清HA、PCⅢ、IV—C有明显下降,肝组织病理改变明显改善,为目前有效的慢性乙肝治疗措施。 相似文献